COVID-19 in patients with rheumatological diseases treated with anti-TNF

Ann Rheum Dis. 2021 May;80(5):e62. doi: 10.1136/annrheumdis-2020-218171. Epub 2020 Jun 16.

Authors

Carlos Antunes Brito^{1

2}, José Gerardo Paiva³, Fernando Nunes Pimentel², Rosinete Santos Guimarães², Mariana Ribeiro Moreira²

Affiliations

¹ Internal Medicine, Federal University of Pernambuco, Recife, Brazil cbritoc@gmail.com.
² Department of Immunology, Autoimmune Research Institute, Recife, Pernambuco, Brazil.
³ Department of Rheumatology, General Hospital César Cals, Fortaleza, Ceará, Brazil.

PMID: 32546603
DOI: 10.1136/annrheumdis-2020-218171

No abstract available

Keywords: Behcet syndrome; ankylosing; arthritis; biological therapy; rheumatoid; spondylitis.

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents* / therapeutic use
COVID-19*
Humans
Rheumatic Diseases* / drug therapy
SARS-CoV-2
Spondylitis, Ankylosing* / drug therapy
Tumor Necrosis Factor Inhibitors

Substances

Antirheumatic Agents
Tumor Necrosis Factor Inhibitors